- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:39 | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial | 200 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial 16.07.2026... ► Artikel lesen | |
| 29.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Added to Russell Microcap(R) Index | 305 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Added to Russell Microcap(R) Index 29.06.2026 / 14:35 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| 25.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 353 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 25.06.2026 / 23:03 CET/CEST
The issuer... ► Artikel lesen | |
| 16.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index | 331 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index 16.06.2026 / 14:35 CET/CEST
The issuer... ► Artikel lesen | |
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 08.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time | 325 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m.... ► Artikel lesen | |
| 28.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 | 374 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting... ► Artikel lesen | |
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 22.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 | 500 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026... ► Artikel lesen | |
| 22.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 18.05. | Trotz verfehlter Q2-Prognosen: NeuroOne-Aktie im Aufwind | 3 | Investing.com Deutsch | ||
| 12.05. | NeuroOne Medical Tech Q2 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| 12.05. | NeuroOne Medical Technologies GAAP EPS of -$0.25 misses by $0.02, revenue of $2.4M misses by $0.18M | 1 | Seeking Alpha | ||
| 12.05. | NeuroOne outlines ISO 13485 certification in latter part of 2026 while targeting drug delivery availability in second half of fiscal 2026 | 2 | Seeking Alpha | ||
| 12.05. | NeuroOne verfehlt Q2-Prognosen: Aktie gibt nach | 1 | Investing.com Deutsch | ||
| 12.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update | 1.301 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update 12.05.2026 / 14:03 CET/CEST
The... ► Artikel lesen | |
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 04.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement | 299 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement 04.05.2026 / 14:34 CET/CEST
The issuer is solely... ► Artikel lesen | |
| 30.04. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Chief Financial Officer Succession Plan | 482 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Announces Chief Financial Officer Succession Plan 30.04.2026 / 14:32 CET/CEST
The issuer is solely... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,650 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide CSF Assay Platform | HOUSTON and LAKE FOREST, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company") and Genomic Testing Cooperative, LCA ("GTC") today announced a collaboration... ► Artikel lesen | |
| ORGANON | 11,720 | -0,34 % | Samsung Bioepis and Organon Broaden Biosimilar Access in Australia Through Expanded Commercialisation Agreement | ||
| QUIDELORTHO | 15,540 | -2,20 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| NANO-X IMAGING | 1,075 | -0,46 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| ROCKWELL MEDICAL | 5,650 | +0,18 % | H.C. Wainwright hebt Kursziel für Rockwell Medical Aktie auf 20 $ an | ||
| NUWELLIS, INC | 3,030 | -2,88 % | Nuwellis, Inc.: Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies | MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,140 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| NEURONETICS | 1,750 | +8,70 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| PULSE BIOSCIENCES | 22,000 | -4,35 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| OPTIMIZERX | 6,655 | +0,08 % | OptimizeRx Corporation: OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| PAVMED | 5,110 | +7,24 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 9,550 | +2,69 % | CMS-Kehrtwende bei Kostenerstattung: Canaccord bestätigt "Buy"-Rating für Orthofix Medical | ||
| OWLET | 6,140 | -0,65 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo | ||
| QTREX QUANTUM | 1,425 | +0,35 % | NSE - QTREX Quantum Ltd. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| PICARD MEDICAL | 0,149 | 0,00 % | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,030 (-1,20 %) liegt der Kurs bei 2,480 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.